These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24952759)

  • 1. Current readings: management of N2 disease for lung cancer.
    Wigle DA
    Semin Thorac Cardiovasc Surg; 2014; 26(1):67-70. PubMed ID: 24952759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.
    Veeramachaneni NK; Feins RH; Stephenson BJ; Edwards LJ; Fernandez FG
    Ann Thorac Surg; 2012 Sep; 94(3):922-6; discussion 926-8. PubMed ID: 22742842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Our experience with patients operated after neoadjuvant therapy].
    Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
    Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection.
    Tanner NT; Gomez M; Rainwater C; Nietert PJ; Simon GR; Green MR; Silvestri GA
    J Thorac Oncol; 2012 Feb; 7(2):365-9. PubMed ID: 22237260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.
    Suntharalingam M; Paulus R; Edelman MJ; Krasna M; Burrows W; Gore E; Wilson LD; Choy H
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):456-63. PubMed ID: 22543206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
    Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
    J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum Drug Sensitivity Polymorphisms in Stage III Non-small Cell Lung Cancer With Invasion of Mediastinal Lymph Nodes.
    Nastase A; Lupo A; Laszlo V; Damotte D; Dima S; Canny E; Alifano M; Popescu I; Klepetko W; Grigoroiu M
    Cancer Genomics Proteomics; 2020; 17(5):587-595. PubMed ID: 32859637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of induction treatment for N2-Stage III non-small cell lung cancer.
    Yamaguchi M; Sugio K
    Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):651-9. PubMed ID: 25355643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of a patient with stage IIIA (N2) NSCLC.
    Carlson K; Fowler BZ; Miller DL; Gal A; Ramalingam S
    Oncology (Williston Park); 2008 Apr; 22(5):553-7; discussion 557-9. PubMed ID: 18533405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
    Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer.
    Ripley RT; Suzuki K; Tan KS; Adusumilli PS; Huang J; Park BJ; Downey RJ; Rizk NP; Rusch VW; Bains M; Jones DR
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):969-77, 979.e1-3. PubMed ID: 26614420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.
    Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D
    Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.